Mapping the immune system might result in the creation of medicine that assist our our bodies win the combat towards most cancers and different illnesses. That’s the massive concept behind immunotherapy. The issue: the immune system is extremely advanced.
Enter Immunai, a biotech firm that’s utilizing cutting-edge genomics & ML expertise to map the human immune system and develop new immunotherapies towards most cancers and autoimmune illnesses.
On this episode of NVIDIA’s AI Podcast, host Noah Kravitz spoke with Luis Voloch, co-founder and CTO of Immunai, about tackling the challenges of the immune system with a machine studying and knowledge science mindset.
You Would possibly Additionally Like
It might appear intuitive that AI and deep studying can pace up workflows — together with novel drug discovery, a usually years-long and several-billion-dollar endeavor. Nevertheless, there’s a dearth of latest analysis reviewing how accelerated computing can affect the method. Professors Artem Cherkasov and Olexandr Isayev talk about how GPUs will help democratize drug discovery.
Is it doable to govern issues along with your thoughts? Probably. College of Minnesota postdoctoral researcher Jules Anh Tuan Nguyen discusses permitting amputees to manage their prosthetic limbs with their ideas, utilizing neural decoders and deep studying.
Learning endangered species will be troublesome, as they’re elusive, and the act of observing them can disrupt their lives. Sifei Liu, a senior analysis scientist at NVIDIA, discusses how scientists can keep away from these pitfalls by learning AI-generated 3D representations of those endangered species.
Subscribe to the AI Podcast: Now Obtainable on Amazon Music
Now you can hearken to the AI Podcast by Amazon Music.
Additionally get the AI Podcast by iTunes, Google Podcasts, Google Play, Castbox, DoggCatcher, Overcast, PlayerFM, Pocket Casts, Podbay, PodBean, PodCruncher, PodKicker, Soundcloud, Spotify, Stitcher and TuneIn.
Make the AI Podcast higher: Have a couple of minutes to spare? Fill out our listener survey.